Qingquan Tang

Title: Innovations by Qingquan Tang in Respiratory Viral Infections

Introduction

Qingquan Tang is an accomplished inventor based in Gaithersburg, MD (US). He has made significant contributions to the field of medical science, particularly in the treatment of respiratory viral infections. His innovative work focuses on developing compositions that utilize siRNA to combat viral replication.

Latest Patents

Qingquan Tang holds a patent for "Compositions for treating respiratory viral infections and their use." This invention provides siRNA compositions that interfere with viral replication in respiratory viral infections, including respiratory syncytial virus and avian influenza A, specifically the H5N1 strain. The invention outlines the use of these siRNA compositions to inhibit the expression of viral genes in infected cells, offering potential treatments for respiratory virus infections in subjects. The invention includes polynucleotides that target the genome of respiratory syncytial virus or influenza A virus, as well as vectors, cells, and pharmaceutical compositions containing siRNA sequences.

Career Highlights

Qingquan Tang is associated with Sirnaomics, Inc., where he continues to advance his research and innovations. His work has garnered attention for its potential impact on public health, particularly in the context of viral outbreaks.

Collaborations

Some of his notable coworkers include Patrick Y Lu and Martin Woodle, who contribute to the collaborative efforts in research and development at Sirnaomics, Inc.

Conclusion

Qingquan Tang's innovative contributions to the treatment of respiratory viral infections highlight the importance of siRNA technology in modern medicine. His work not only advances scientific understanding but also offers hope for effective treatments against viral diseases.